Technical Analysis for CORI - Corium International, Inc.

Grade Last Price % Change Price Change
grade F 8.43 -0.94% -0.08
CORI closed down 0.94 percent on Friday, May 25, 2018, on 67 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical CORI trend table...

Date Alert Name Type % Chg
May 25 NR7 Range Contraction 0.00%
May 25 Lower Bollinger Band Walk Weakness 0.00%
May 25 Inside Day Range Contraction 0.00%
May 25 Oversold Stochastic Weakness 0.00%
May 24 Slingshot Bearish Bearish Swing Setup -0.94%
May 24 Bullish Engulfing Bullish -0.94%
May 24 Lower Bollinger Band Walk Weakness -0.94%
May 24 Lower Bollinger Band Touch Weakness -0.94%
May 24 Oversold Stochastic Weakness -0.94%
May 23 Calm After Storm Range Contraction 2.80%

Older signals for CORI ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Corium International, Inc., a biopharmaceutical company, focuses on the research, development, manufacture, and commercialization of specialty pharmaceutical products. Its products include Clonidine Transdermal Delivery System (TDS), a treatment for hypertension; Fentanyl TDS, a treatment for management of chronic pain, including cancer-related pain; Crest Whitestrips, a series of four products under the Advanced Vivid, Professional Effects, One Hour Express, and Flex-Fit brands for oral care. The company is also developing AG200-15, a combination hormonal contraceptive patch in Phase III clinical trials that delivers ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system, which has completed Phase I clinical trials for the treatment of severe osteoporosis; and Corplex Tamsulosin that has completed Phase I clinical trials for the treatment of benign prostatic hyperplasia. In addition, its products that have completed development, scale-up, and clinical activities include motion sickness patch for the prevention of nausea and vomiting associated with motion sickness; and urology patch for treatment of a urologic condition. Further, the company is developing Donepezil and Memantine transdermal patches for the treatment of Alzheimer's disease; and Ropinerole and Pramipexole therapies for the treatment of Parkinson's disease. Corium International, Inc. has collaboration agreements with The Procter & Gamble Company, Teva Pharmaceuticals USA, Inc., Par Pharmaceutical, Inc., and Agile Therapeutics, Inc. The company was incorporated in 1995 and is headquartered in Menlo Park, California.
Is CORI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 13.93
52 Week Low 6.77
Average Volume 291,276
200-Day Moving Average 10.657
50-Day Moving Average 10.1658
20-Day Moving Average 9.2465
10-Day Moving Average 8.827
Average True Range 0.4937
ADX 46.21
+DI 10.1
-DI 31.02
Chandelier Exit (Long, 3 ATRs ) 8.7689
Chandelier Exit (Short, 3 ATRs ) 9.5811
Upper Bollinger Band 10.3913
Lower Bollinger Band 8.1017
Percent B (%b) 0.14
BandWidth 24.761802
MACD Line -0.5333
MACD Signal Line -0.4742
MACD Histogram -0.0592
Fundamentals Value
Market Cap 301.3 Million
Num Shares 35.7 Million
EPS -1.72
Price-to-Earnings (P/E) Ratio -4.90
Price-to-Sales 10.96
Price-to-Book 12.08
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.82
Resistance 3 (R3) 8.82 8.70 8.76
Resistance 2 (R2) 8.70 8.60 8.70 8.73
Resistance 1 (R1) 8.56 8.54 8.50 8.56 8.71
Pivot Point 8.44 8.44 8.41 8.44 8.44
Support 1 (S1) 8.30 8.34 8.24 8.30 8.15
Support 2 (S2) 8.18 8.28 8.18 8.13
Support 3 (S3) 8.04 8.18 8.11
Support 4 (S4) 8.04